Skip to main content

RHUMBLINE ADVISERS

Position in PCRX — Pacira BioSciences, Inc.

CIK 1115418 BOSTON, MA

Position in PCRX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$2,777,879
-$530,930 QoQ
Shares Held
122,915
-3.9% QoQ
Ownership
0.312%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 42.07053654964813.ToString("F0")% Shared 0.ToString("F0")% None 57.92946345035187.ToString("F0")%

Common Shares in PCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $438,094,582 across 50 Drug Manufacturers - Specialty & Generic names. PCRX ranks #20 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PCRX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,777,879 122,915
2025-12-31 $3,308,809 127,852
2025-09-30 $3,718,714 144,304
2025-06-30 $3,567,194 149,255
2025-03-31 $3,586,327 144,319
2024-12-31 $2,902,735 154,073
2024-09-30 $2,427,083 161,268
2024-06-30 $4,562,350 159,467
2024-03-31 $4,371,253 149,598
2023-12-31 $5,024,054 148,905
2023-09-30 $4,329,653 141,123
2023-06-30 $5,611,763 140,049
2023-03-31 $5,595,826 137,119
2022-12-31 $5,040,265 130,543
2022-09-30 $6,963,741 130,922
2022-06-30 $7,324,520 125,635
2022-03-31 $8,930,355 117,012
2021-12-31 $6,644,392 110,427
2021-09-30 $6,120,632 109,297
2021-06-30 $7,557,572 124,548
2021-03-31 $8,830,989 125,995
2020-12-31 $7,520,152 125,671
2020-09-30 $7,160,893 119,110
2020-06-30 $7,111,468 135,534
2020-03-31 $4,729,708 141,059